Arthritis pain relief is significantly improved lately with a new device that's closing the therapeutic gap between drugs and surgery for osteoarthritis of the knee.
The BioniCare Knee Device is the first and only non-drug, non-invasive treatment for osteoarthritis of the knee cleared by the FDA for marketing in the United States. The Device is intended for use as an adjunctive therapy in reducing the level of pain and symptoms associated with osteoarthritis of the knee and for overall improvement of the knee as assessed by physicians' global evaluation (http://www.rsmedical.com).
The Device represents a safe and effective option for the management of osteoarthritis of the knee for patients whose pain and other symptoms are not controlled by appropriate drug therapy alone, and who are unable or unwilling to undergo knee replacement surgery.
The BioniCare Knee Device delivers a specific electrical signal to create a new kind of therapy:
- Targeted relief of pain and associated symptoms.
- Substantial improvement over baseline NSAID therapy.
- Excellent safety profile.
- Easy for patients to use.
- Targeted relief of pain and associated symptoms.
- Substantial improvement over baseline NSAID therapy.
- Excellent safety profile.
- Easy for patients to use.
